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ABSTRACT 
Elevation of intracellular calcium levels in the presence of normal 
androgen levels has been implicated in apoptotic prostate cell death. 
Since the androgen receptor (AR) plays a critical role in the regulation 
of growth and differentiation of the prostate, it was of interest to 
determine whether Ca” would affect the expression of androgen 
receptor messenger RNA (mRNA) and protein, thus affecting the 
ability of androgens to control prostate function. AR-positive human 
prostate cancer cells, LNCaP, were incubated with either the calcium 
ionophore A23187 or the intracellular endoplasmic reticulum Ca2+- 
ATPase inhibitor thapsigargin. Subsequently, AR mRNA and protein 
levels were assessed by Northern and Western blot analysis. Both 
A23187 and thapsigargin were found to down-regulate steady state 
AR mRNA levels in a time- and dose-dependent manner. AR mRNA 
began to decrease after 6-8 h of incubation with 10-s M A23187 or 
10m7 M thapsigargin, reaching a nadir at 16 and 10 h of incubation, 
respectively. In contrast, control mRNA (glyceraldehyde S-phosphate 
dehydrogenase) did not change significantly during the treatments 
with either A23187 or thapsigargin. AR protein levels were found to 
be decreased after 12 h of incubation with either 10m6 M A23187 or 
10m7 M thapsigargin. The decrease in AR mRNA and protein seemed 
to precede apoptosis, since neither A23187 (24 h) nor thapsigargin (30 
h) was found to alter cell morphology within the treatment time. 
Cycloheximide and actinomycin D were unable to change the calcium- 
mediated decrease in AR mRNA, ruling out the necessity for de nouo 
protein synthesis or a change in mRNA stability. Moreover, the de- 
crease in AR mRNA induced by calcium does not seem to involve 
protein kinase C- or calmodulin-dependent pathways, since inhibitors 
of these cellular components had no effect. Nuclear run-on assays 
demonstrated little or no effects of either A23187 or thapsigargin 
treatment on AR gene transcription (8 h and 10 h). In conclusion, 
these studies show that intracellular calcium seems to be a potent 
regulator of AR gene expression in LNCaP cells. (Endocrinology 136: 
2172-2178, 1995) 
T HE androgen receptor (AR) belongs to the steroid and thyroid hormone receptor superfamily (1). It mediates 
the effects of testosterone and dihydrotestosterone on 
growth and differentiation of male urogenital organs (2). 
Factors that can modulate the expression of AR may play an 
integral role in these androgen-dependent processes (3). 
It has been shown that several hormones and growth fac- 
tors can regulate the expression of AR. In human cell lines 
and animal models, androgens can autoregulate the expres- 
sion of AR (4, 5). For example, it has been shown that an- 
drogens decrease AR messenger RNA (mRNA) and protein 
levels in the rat prostate and several human cell lines (4-7). 
Conversely, it has been reported that AR mRNA and protein 
levels are increased by the administration of androgens in the 
rat and mouse prostate, as well as in human genital skin 
fibroblasts (g-10). More recently, Krongrad et al. (11) have 
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shown that androgen down-regulation of AR mRNA is as- 
sociated with a transient up-regulation of AR protein in 
LNCaP cells. It is not clear which intracellular mechanism 
mediates this autoregulation process, although transcrip- 
tional down-regulation of AR by androgens in LNCaP cells 
has been reported recently (12, 13). 
At least three distinct second messenger pathways exist 
within the cell: 1) the protein kinase A (PKA)-dependent 
pathway; 2) the PKC-dependent pathway; and 3) the 
calcium-calmodulin kinase-dependent pathway. All three 
pathways have been implicated in the regulation of the AR. 
For example, FSH, which activates the IX4 pathway, can 
stimulate the expression of AR mRNA and protein in the rat 
Sertoli cell (14) (characterization of the mouse AR and human 
AR (hAR) 5’-flanking regions indicated that sequences con- 
tained within the 5’-flanking region can mediate some of the 
effects of the PKA pathway on AR expression; 15, 16); epi- 
dermal growth factor, which activates the PKC pathway, can 
decrease AR mRNA levels in the human prostate cancer cell 
line LNCaP (17); and calcitonin, which alters Ca+’ homeosta- 
sis, increases AR protein levels in rat Leydig cells (18). 
The withdrawal of androgens from the prostate results in 
massive programmed cell death. It has been indicated that 
calcium ion influx into the cells may play a role in the path- 
way leading to androgen-induced apoptosis (19). Moreover, 
Martikainen and Issacs (20) has shown that in a rat ventral 
prostate organ culture system, an elevation of intracellular 
calcium in the presence of normal androgen levels could 
increase apoptosis to a similar level as caused by androgen 
2172 
 at Medical Library Erasmus MC on February 23, 2007 endo.endojournals.orgDownloaded from 
CALCIUM REGULATION OF AR IN LNCaP CELLS 
ablation. Given these data, it seemed worthwhile to inves- 
tigate whether increased intracellular calcium levels would 
affect AR mRNA and protein levels, and thereby affect the 
ability of androgens to control prostate function. Therefore, 
we have examined the role of calcium in the regulation of AR 
mRNA and protein expression in the human prostate cancer 
cell line LNCaP, using Northern and Western blotting 
analyses. 
Materials and Methods 
Materials and cell culture 
A23187, thapsigargin, staurosporine, and trifluoperazine were dis- 
solved in dimethyl sulfoxide (DMSO). Cycloheximide and actinomycin 
D were dissolved in water. All were purchased from Sigma Chemical Co. 
(St Louis, MO), except A23187, which was a gift from Dr. C. Y.-F Young 
(Mayo Clinic). The synthetic androgen mibolerone (Upjohn, Kalamazoo, 
Ml) was dissolved in ethanol. The final concentration of DMSO or 
ethanol in the culture medium was 0.1%. RPM1 1640 culture medium 
was purchased from CELOX Co. (Hopkins, MN). Trypsin-EDTA, anti- 
biotics, and fungizone were purchased from GIBCO (Gaithersburg, 
MD). 
The human prostate cancer cell LNCaP (21) was obtained from the 
American Type Culture Collection (Rockville, MD). LNCaP cells (30-60 
passages) were maintained in RPM1 1640 as a monolayer in the presence 
of 5% fetal calf serum (FCS) and 2 mM glutamine. The medium was 
changed every 3-4 days. Cells used in the-experiment were first grown 
to 70-80% confluence in 5% FCS RPM1 1640, then cultured in serum-free 
media for 24 h, after which the medium was replaced by 1% charcoal- 
stripped FCS RPM1 1640 with added hormones. For the actinomycin D 
experiment, cells were incubated for 8 h with DMSO or thapsigargin 
before incubating in fresh medium for the indicated period with 5 &ml 
actinomycin D. 
3-(4, 5-Dimethylthiazole-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay 
To assess the growth rate of cells, a modification of the MTT assay was 
used (22). Cells were trypsinized, resuspended in RPM1 1640 medium 
with 1% charcoal-stripped FCS, and O.l-ml aliquots (10,000 cells) were 
plated into 96-well plates and cultured for 2 days. Aliquots of culture 
medium containing the calcium ionophore or thapsigargin (50 ~1) were 
added to reach the final concentrations indicated in the experiment. At 
the end of the incubation period, the medium was carefully removed by 
inverting the plates on a paper towel, and 50 ~1 of a 0.5 m&ml solution 
of MTT in culture medium with 1% charcoal-stripped FCS was added. 
After 4 h of incubation with MTT at 37 C, 0.15 rni bMS0 was added to 
each well. The plates were placed on a shaker for 5 min, and the ab- 
sorbance at 550 nm was read usine. a multiwell ulate reader (SLT Lab 
Instruments, model EAR 400 AT). SK wells were u\ed for each test point. 
Wells containing medium, but no cells, served as blank controls. 
RNA extraction and Northern blot analysis 
Total RNA was obtained by lysing the cells in LiCl (3 M) and urea (6 
M) (23). Samples were homogenized on ice for 1 min at 24,000 rpm with 
a Tissuemizer (Kunkel, Staufen, Germany) and incubated at -20 C for 
30 min. Samples were centrifuged for 20 min at 80,000 x g. Pellets were 
resuspended in ES solution [O.l% sodium dodecyl sulfate (SDS) and 0.2 
mM EDTA], extracted once with phenol/chloroform/isoamyl alcohol 
and once with chloroform/isoamyl alcohol, and precipitated with a 1:9 
vol of 3 M sodium acetate (pH 5.2) and 2.5 vol ethanol. The RNA pellet 
was resuspended in water and was quantified by reading the absorbance 
at 260 and 280 nm. RNA was separated by electrophoresis on a 1% 
agarose gel, which contained 2% formaldehyde, using 1 X MOPS buffer 
(20 mM 3-A-morpholino propansulfonic acid, pH 7.0, 5 mM sodium 
acetate, and 1 mM EDTA). The RNA was transferred to a Hybond-N or 
Hybond-N+ membrane (Amersham, Arlington Heights, IL) and was 
UV cross-linked to the membrane using a stratalinker (Stratagene, San 
Diego, CA). 
The hAR probe for Northern analysis [542-base pair pvull-pvull com- 
plementary DNA (cDNA) fragment] was generated by digesting the 
full-length hAR cDNA (24) with pvull. The housekeeping enzyme glyc- 
eraldehyde 3-phosphate dehydrogenase (GAPDH; 740-base pair pstl- 
pstl cDNA fragment) was generated by cutting the plasmid, which 
contained GAPDH, with pstl. The cDNA was labeled with [ol-32PJdeoxy- 
ATP using a random-primed labeling kit (Boehringer Mannheim, lndi- 
anapolis, IN). The reaction was incubated at 22 C for 1 h, and the labeled 
cDNA probe was separated from free nucleotides by passage through 
Sephadex G-50 packed in a 5-ml pipette and added birectiy into tlhe 
hvbridization buffer 150% formamide, 0.5% SDS, 6X SSC (1 X SSC = 150 i 
mM sodium chloride and 15 mM sod’ium citrate), 5X Denhardt’s solu- 
tion, 10 mM phosphate buffer, and 100 pg/ml salmon sperm DNA]. 
Northern blots were prehybridized for 1 h at 42 C and then hybridized 
with labeled probes overnight at 42 C. Blots were washed twice in 2X 
SSC and 0.1% SDS at room temperature for 15 min and once in 0.1 X SSC 
and 0.1% SDS at 65 C for 15 min, quantified with a Phosphorlmager 425 
(Molecular Dynamics, Sunnyvale, CA), and exposed to x-ray film. 
Immunoblotting 
Cellular proteins were isolated by homogenizing the cells in 10 mM 
Tris-HCl. uH 7.5. 1 mM EDTA. uH 8.0, 10 mM M&l,, 1% SDS, 0.25 M 
sucrose, k’pg/mi leupeptin, 1 ;n’~ phenylmethyls\lfonyl fluoride, and 
5 pg/ml bacitracin for five strokes. The lysates were dialyzed against 
water overnight, lyophilized, and reconstituted in water. Equal amounts 
of protein (10 Kg/lane) were passed through a 10% precast gel (NOVEX, 
San Diego, CA) at 150 V for 2 hat 4 C. Resolved proteins were transferred 
electrophoretically to nitrocellulose (Bio-Rad, Hercules, CA) at 4 C for 
3 hat 30 mA in a buffer containing 25 mM glycine, 192 mM Tris, and 10% 
methanol. Nonspecific binding of the antibodies to the membranes was 
diminished by tireincubating yhe blots in TBS (50 mM Tris-HCl and 150 
mM NaCl. DH 7.4) in the Dresence of 3% drv milk for 1 h at room 
tempera&l. Blots were i&bated with rabbit anti-AR antibody (0.5 
pg/ml PG-21, kindly provided by Dr. Gail Prins, University of Illinois 
School of Medicine, Chicago, IL) (25) in the presence or absence of a 
IO-fold molar excess of AR21 peptide (0.1 pg/ml) in TBS containing 1% 
dry milk and 0.2% Tween-20 (Bio-Rad) at 4 C for 24-48 h and then with 
a peroxidase-labeled antirabbit antibody (1:lOOO dilution; Amersham) in 
the same buffer at room temperature for 1 h. After each incubation, blots 
were washed twice with TBS containing 0.2% Tween-20 for 10 min. 
lmmunoreactive bands were visualized using an enhanced chemilumi- 
nescence kit (Amersham). 
Nuclear run-on 
The nuclear run-on assay was performed as described by Blok et al. 
(14). Cloned cDNAs (5 pg/slot) used to detect the mRNA transcription 
rate of AR and GAPDH genes were: Bluescript 11 SK? (Stratagene, La 
Jolla, CA) linearized with EcoRl as a background control, pBlueAR (26) 
linearized with Hind111 for AR, and pGAPDH (Clontech, Palo Alto, CA) 
linearized with Pstl for GAPDH. Culture conditions were as described 
previously; the time points at which the cells were harvested for nuclei 
isolation for the transcription elongation reaction were 8 and 10 h after 
A23187 or thapsigargin was administered to the LNCaP cells. Hybrid- 
ization was performed at 65 C for 72 h; washing of the blots was 
performed in 1 x SSC and 0.5% SDS at 55 C for 30 min. The film was 
exposed for 72 h. 
Results 
To determine whether intracellular levels of calcium af- 
fected the expression of the AR, the AR-containing cell line 
LNCaP was treated with the calcium ionophores A23187 
(lo-” M) or ionomycin (lOeh M), or the intracellular Ca*+- 
ATPase inhibitor thapsigargin (lop7 M), for 16 h. RNA was 
analyzed on Northern blots incubated with an hAR cDNA 
probe. Three major AR mRNAs of 11, 8, and 4.7 kilobases 
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were detected (Fig. 11, which were of similar sizes to those 
reported previously for AR mRNA in LNCaP cells (27). The 
expression of all three AR transcripts decreased after treat- 
ment with A23187, ionomycin, or thapsigargin. 
The time dependencies of A23187 and thapsigargin down- 
regulation of AR were examined next. Levels of AR tran- 
scripts in LNCaP cells began to decrease after 6-8 h of 
incubation with A23187 (lop6 M), reached a nadir after 16 h 
of incubation (29% of control), and increased to 59% of the 
control level at 24 h (Fig. 2). Thapsigargin (lo-’ M) treatment 
also resulted in a reduction in AR transcripts, decreasing 
after 6-8 h of incubation, reaching 23% of the control level 
after 10 h, and increasing to 68% of control by 24 h (Fig. 2). 
Next, the dose response of AR mRNA to A23187 and 
thapsigargin was examined. An 8-h treatment with thapsi- 
gargin reduced AR mRNA levels at doses as low as 50 nM, 
whereas higher concentrations of A23187 (about 500 nM) 
were required to reduce AR mRNA levels (Fig. 3). These 
doses are similar to those reported previously for biological 
effects of these compounds (28). Next, AR protein levels were 
examined. As shown in Fig. 4, low6 M A23187 and lo-’ M 
LNCaP cells 
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FIG. 1. Calcium regulation of AR mRNA levels in human prostate 
cancer LNCaP cells. LNCaP cells were treated with lOme M A23187, 
lo-’ M ionomycin, or 10e7 M thapsigargin for 16 h. Total RNA was 
extracted and analyzed on Northern blots (20 &lane), which were 
hybridized with an hAR ~~uII-~vuII cDNA probe. The filter was 
rehybridized with a housekeeping enzyme GAPDH cDNA probe to 
verify equal loading. AR transcripts are indicated by the arrows. 
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FIG. 2. Time course of calcium ionophore A23187 and thapsigargin 
regulation of AR mRNA in LNCaP cells. LNCaP cells were treated 
with 10m6 M A23187 or 10e7 M thapsigargin for various periods of time 
(O-24 h). Total RNA was extracted and analyzed on Northern blots 
(20 pg/lane) with an hAR cDNA probe. The filter was rehybridized 
with GAPDH cDNA to correct for variations in the loading of RNA. 
The graph represents the mean of two independent experiments. 
Thapsigargin 
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FIG. 3. Dose dependency of calcium ionophore A23187 and thapsi- 
gargin regulation of AR mRNA in LNCaP cells. LNCaP cells were 
treated with A23187 (100-1000 no) or thapsigargin (l-100 no) for 8 
h. Total RNA was extracted and analyzed on Northern blots (20 
pg/lane) with an hAR cDNA probe. The filter was rehybridized with 
GAPDH cDNA. The graph represents the mean of two independent 
experiments. 
thapsigargin effectively reduced AR protein levels after 12 h 
of incubation. However, at 24 h of incubation with either 
compound, the AR protein levels had almost returned to 
control levels. 
Calcium has been reported to induce apoptosis in prostate 
epithelial cells (19, 20). To determine whether the observed 
effects on the AR were the result of apoptosis, LNCaP cells 
were incubated with different concentrations of A23187 or 
thapsigargin for various lengths of time (Fig. 5). At the end 
of the experiments, no morphological differences were ob- 
served between control cells incubated with DMSO or cells 
treated with A23187 or thapsigargin (data not shown). Fur- 
thermore, A23187 had no effect on the growth rate of the 
LNCaP cells as measured by the MTT assay, indicating the 
viability of the cells. In the presence of thapsigargin, how- 
ever, LNCaP cells became arrested in growth (Fig. 5). The 
first morphological indications for apoptosis were observed 
after 36 h of culture in the presence of A23187 and 12 h later 
for thapsigargin (48 h; data not shown). These results suggest 
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blG. 4. Western blot analysis of AR protein expression. LNCaP cells 
were treated with low6 M A23187 or 10m7 M thapsigargin for 12 and 
24 h. Total cellular proteins were isolated and separated by SDS 
polyacrylamide gel electrophoresis. Immunological detection was per- 
formed using the PG-21 antibody either in the absence (left panel) or 
presence (rig& panel) of the AR21 peptide as described in Materials 
anal Methods. The positions of the molecular mass markers (in kilo- 
daltons) are shown on the right. The major immunoreactive band is 
at 110 kilodaltons. This experiment was repeated twice. 
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FIG. 5. Calcium ionophore A23187 and thapsigargin regulation of 
LNCaP cell growth rate. LNCaP cells were treated with vehicle 
(DMSO) alone or various concentrations of A23187 and thapsigargin 
for the different periods of time. At the end of treatment, cells were 
incubated with 0.5 mg/ml M’l’l’ for 4 h. Cells were lysed in DMSO, and 
550 nm absorbance was measured by a multiwell plate reader. Viable 
cells at each dose are expressed as the percentage of control at that 
time (mean t SEM, n = 6; for thapsigargin the SEM was less than 3% 
and, consequently, could not be depicted in the graph). This experi- 
ment was repeated twice. 
that calcium-induced apoptosis is preceded by a down- 
regulation of AR mRNA levels in LNCaP cells. 
To explore the mechanism of calcium regulation of AR 
mRNA expression in LNCaP cells, we measured the effects 
of various inhibitors on the regulatory pathways in LNCaP 
cells. The dosages of these drugs and the time frames of the 
experiments were based on our previous experiences using 
endometrial carcinoma cell lines (29). The 30-min pretreat- 
ment of the cells with either cycloheximide, staurosporine, or 
trifluoperazine was performed to allow these compounds to 
exert their actions before intracellular calcium became in- 
creased. Cycloheximide was used to inhibit protein synthesis 
(30); staurosporine was used to inhibit PKC (31); and triflu- 
operazine was used to inhibit calmodulin (32). None of these 
inhibitors affected the AR mRNA levels, nor did they prevent 
the calcium down-regulation of AR mRNA levels (Fig. 6). 
The lack of effect of staurosporine and trifluoperazine sug- 
gests that a pathway other than PKC or calmodulin might be 
involved. 
Since cycloheximide had no effect, de ~ODO protein syn- 
thesis did not seem to be involved in the calcium effects on 
AR mRNA expression. Thus, the effect of calcium might be 
due to a posttranscriptional change in the half-life of the 
message. Therefore, we measured the effects of thapsigargin 
on AR mRNA half-life. LNCaP cells were incubated with 
DMSO or thapsigargin for 8 h and then treated with the RNA 
synthesis inhibitor actinomycin D (5 pg/ml) for different 
periods of time (O-24 h). As shown in Fig. 7, the half-life of 
the AR mRNA in DMSO-treated LNCaP cells was 7.5 h. For 
thapsigargin-treated LNCaP cells, the half-life of AR mRNA 
was 8.1 h. This experiment showed that an accelerated turn- 
over of AR mRNA in the presence of thapsigargin was not 
detectable in LNCaP cells, suggesting that a posttranscrip- 
tional mechanism of calcium down-regulation of AR mRNA 
in LNCaP cells was unlikely. 
We next asked whether transcription of the AR gene was 
affected by A23187 or thapsigargin. Transcription of the AR 
gene in LNCaP cells, cultured in the presence of A23187 or 
thapsigargin, was measured using a nuclear run-on assay. As 
shown in Fig. 8, transcription of both the AR gene and the 
AR 
GAPDH 
FIG. 6. Cycloheximide, staurosporine, and trifluoperazine effects on 
calcium ionophore A23187 and thapsigargin down-regulation of AR 
mRNA in LNCaP cells. LNCaP cells were treated with cycloheximide 
(10 @g/ml), staurosporine (lo-’ M), or trifluoperazine (10m6 M) for 30 
min before adding A23187 (10-s M) or thapsigargin (low7 M). Cells 
were incubated with A23187 or thapsigargin for 8 h. Total RNA was 
isolated and subjected to Northern blot analysis with bAR and 
GAPDH cDNA probes. This experiment was repeated twice. 
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FIG. 7. Thapsigargin regulation of the AR mRNA half-life in LNCaP 
cells. LNCaP cells were treated with vehicle (DMSO) alone or thap- 
sigargin (10m7 M) for 8 h and then incubated with actinomycin D (5 
&ml) for the indicated time. Total RNA was isolated and subjected 
to Northern blot analysis with hAR and GAPDH cDNA probes. The 
half-life of AR mRNA under each treatment was calculated by a 
regression analysis of the slopes of the line. The graph represents the 
mean of three independent experiments. 
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FIG. 8. Nuclear run-on. LNCaP cells were treated with lo-’ M 
A23187 or 10e7 M thapsigargin for 8 or 10 h, respectively. Transcrip- 
tion elongation was allowed to continue for 30 min before total RNA 
was isolated from the nuclei of control and treated cells. The radio- 
actively labeled RNAs were hybridized to: pBlue, background control 
vector; AR, mouse AR cDNA; and GAPDH, which serves to correct for 
variations in the loading of labeled RNA. This experiment was re- 
peated twice. 
GAPDH gene could be measured. However, no inhibition of 
AR gene transcription in LNCaP cells after 8 or 10 h of 
incubation in the presence of either A23187 or thapsigargin 
was observed, indicating that AR gene transcription is not 
affected by either A23187 or thapsigargin treatments. How- 
ever, it is possible that the effects of both drugs on AR gene 
transcription were weak and consequently not detected us- 
ing a nuclear run-on assay (12). 
Discussion 
The prostate is dependent on circulating concentrations of 
androgens and the presence of androgen receptors for nor- 
mal growth, differentiation, and maintenance of differenti- 
ated functions (2,3). Thus, factors that regulate expression of 
the AR presumably regulate the ability of androgens to con- 
trol prostate function. For example, it has been demonstrated 
that retinoic acid can down-regulate both AR protein levels 
and androgenic induction of prostate-specific androgen and 
hK2 mRNAs in LNCaP cells (33). 
The studies reported in this paper demonstrated that cal- 
cium can also modulate the expression of AR protein and 
mRNA in LNCaP cells. Thus, two distinct pathways, calcium 
and retinoic acid, are able to regulate AR expression and 
consequently androgen effects in the prostate. 
In the current study two compounds, A23187 and thap- 
sigargin, were used to increase intracellular calcium levels in 
LNCaP cells. A23187 is a Ca2+ ionophore, widely used to 
analyze the role of Ca2+ in the regulation of gene expression 
(3436). However, several disadvantages in the use of 
A23187 have been reported; A23187 has pleiotropic effects 
(34,36), and A23187 administration sometimes gives rise to 
a mixed Ca2+ and CAMP signal (35, 36). Therefore, we also 
used the specific endoplasmic reticulum Ca2+-ATPase in- 
hibitor thapsigargin. Its effects are reported to be highly 
specific by initiating only one event: a rapid increase in 
cytosolic free Ca2+. Thapsigargin has been reported to be a 
potent tumor promoter, inducing growth- and transforma- 
tion-related genes in NIH3T3 cells (36). Its role in LNCaP 
cells, however, seems to be directly opposite of these obser- 
vations, as will be described below. 
Since calcium has been reported to mediate apoptosis in 
the rat ventral prostate (19, 20), we tested the possibility of 
whether the down-regulation of AR by calcium could be due 
to the initiation of apoptosis. In our experiments, the calcium 
ionophore A23187 had no effect on cell growth or morphol- 
ogy, indicating that these cells were viable within the ex- 
perimental setup. Thapsigargin treatment of the LNCaP 
cells, however, caused growth arrest. We do not think ap- 
optosis is involved in thapsigargin-induced growth arrest, 
because the morphology of the cells remained unchanged 
during the 30-h incubation period (the first morphological 
changes were observed after 48 h; cells were rounding up and 
24 h later were detaching from the plastic). Also, it has been 
demonstrated previously that cycloheximide can prevent 
calcium-induced apoptosis (37), suggesting that calcium- 
induced apoptosis of prostate cells requires new protein 
synthesis. However, in our studies, cycloheximide did not 
reverse the calcium effect on AR gene expression. Finally, 
expression of the housekeeping enzyme GAPDH was stable 
during treatment with either the calcium ionophore or thap- 
sigargin. Our data suggest that the effect of calcium on AR 
mRNA occurs before apoptotic activation in LNCaP cells. 
Several studies have shown that the calcium ionophore 
A23187 and thapsigargin can selectively activate gene ex- 
pression (36,38) or inactivate gene expression via increasing 
intracellular calcium levels (28, 39, 40). Recently, calcium- 
activated &-acting elements have been found in the 5’-flank- 
ing region of a glucose- and calcium-regulated grp78 gene 
(41, 42). The sequence of this element is distinct from the 
CAMP response element, which mediates A23187 activation 
of the c-fos promoter (43), and from tetradecanoylphorbol 
acetate- and serum-responsive elements that have been 
shown to mediate thapsigargin activation of the c-jun and 
c-fos promoters (36). Interestingly, sequences within the hAR 
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5’-flanking region show strong homology to the A23178- 
induced elements of thegrp78 gene. Although nuclear run-on 
experiments showed no effect on the regulation of AR gene 
transcription by A23187 or thapsigargin treatment, it is pos- 
sible that this assay is not sensitive enough to pick up rel- 
atively small differences in the gene transcription rate (12); 
therefore, transcriptional regulation of AR mRNA cannot be 
ruled out. 
Calcium effects on gene expression are usually dependent 
on a rapid phosphorylation mechanism mediated by cal- 
modulin or other calcium-regulated kinases. Calcium nor- 
mally induces rapid expression of many genes such as c-jun 
and c-fos. However, inhibition of gene expression by calcium 
usually occurs with a pattern of relatively slow kinetics (39, 
41). Calcium inhibition of the AR gene occurred after 6 h of 
incubation with A23187 and thapsigargin. This would argue 
against fruns-activation of AR via a rapid phosphorylation 
mechanism. The inability of staurosporine, a PKC inhibitor 
(311, and trifluoperazine, a calmodulin inhibitor (32), to re- 
verse the calcium inhibition of AR gene expression also 
supports the argument that calcium down-regulation of AR 
gene expression occurs by a mechanism other than phos- 
phorylation. 
In conclusion, increases in intracellular calcium concen- 
tration by the calcium ionophore or thapsigargin effectively 
reduce AR expression in LNCaP cells. Calcium inhibition of 
AR expression seems to precede calcium-induced apoptotic 
cell death. Furthermore, the mechanism of this reduction 
seems to be different from a pathway in which the calcium 
signal is transduced via a phosphorylation mechanism. 
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